Biopharmaceutical

NORTH CHICAGO, Ill., July 29, 2026 AbbVie announced that the European Commission (EC) has approved RINVOQ® (upadacitinib) for the...

MUMBAI, India and WARREN, N.J., July 28, 2026 Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have...

BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...

SALT LAKE CITY, July 28, 2026 Co-Diagnostics, Inc. has announced two significant milestones that strengthen global preparedness against Ebola...

TAIPEI, July 28, 2026 Dasher Neuroscience Holdings Inc. has successfully completed patient enrollment in its global Phase 2 clinical...

Tel Aviv, Israel & Raleigh, N.C., July 28, 2026 RedHill Biopharma Ltd. has announced significant progress in the emergency...

Amsterdam, Netherlands, July 27, 2026 Royal Philips has reported solid second-quarter 2026 financial results, driven by 4% comparable sales...

Beijing, July 27, 2026 InnoCare Pharma has announced that its novel TYK2 (Tyrosine Kinase 2) inhibitor fadeucravacitinib (ICP-488) successfully...

SAN FRANCISCO, Calif., July 27, 2026 Revagenix, Inc. announced that the first participant has been dosed in the Phase...

QUÉBEC, Canada, July 21, 2026 Devonian Health Group has received Health Canada authorization to initiate a Phase II/III clinical...